ADCY5 and heart failure: However, previous reports on AC5 deficiency in mice and PG-LPS-treated mice suggest that inhibition of cardiac AC subtypes with vidarabine might prevent myocardial cell damage and heart failure in mice treated with PG-LPS at a dose equivalent to the level seen in subclinical PD.